Everyday our team works toward improving global health by developing new therapeutic solutions with greater worldwide access. With our network of partners, we are developing the next generation of best-in-class medicine.
We’re breaking the barrier for LAI adoption
BEPO®, our long-acting injectable (LAI), meets health challenges on a global scale. By addressing issues of compliance, development timelines, tolerance, and costs, BEPO® provides opportunities for our partners to collaborate with us to achieve better outcomes for patients worldwide.
Superior controlled release
Fine tuned release
Customized release profile, longer duration
Innovative in vitro model with real time analysis
Scaled up polymer production in place
Low polymer cost and efficient API usage increases affordability
Patient and clinician friendly
Subcutaneous or local treatment
Improved compliance due to sustained release formulations